NVZMY has been the topic of a number of other research reports. Zacks Investment Research lowered Novozymes A/S – from a hold rating to a strong sell rating in a research note on Tuesday, November 1st. Berenberg Bank raised Novozymes A/S – from a sell rating to a hold rating in a research note on Tuesday, November 1st. Sanford C. Bernstein raised Novozymes A/S – from a market perform rating to an outperform rating in a research note on Thursday, January 5th. Finally, Goldman Sachs Group, Inc. (The) lowered Novozymes A/S – from a neutral rating to a sell rating in a research note on Wednesday, February 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. Novozymes A/S – currently has an average rating of Hold and a consensus target price of $45.00.
Shares of Novozymes A/S – (NASDAQ:NVZMY) opened at 39.39 on Friday. Novozymes A/S – has a 52 week low of $31.57 and a 52 week high of $49.55. The firm’s 50-day moving average is $37.06 and its 200-day moving average is $39.35. The stock has a market capitalization of $11.72 billion and a price-to-earnings ratio of 27.32.
“Novozymes A/S – (NVZMY) Downgraded by J P Morgan Chase & Co” was originally posted by Mideast Time and is the property of of Mideast Time. If you are reading this article on another website, it was copied illegally and republished in violation of United States & international trademark and copyright legislation. The correct version of this article can be accessed at https://www.mideasttime.com/novozymes-as-nvzmy-downgraded-by-j-p-morgan-chase-co/1536890.html.
Novozymes A/S – Company Profile
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.
Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with MarketBeat.com's FREE daily email newsletter.